Clinical Research

The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study

Volume: 1 Number: 1 January 31, 2024
EN

The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study

Abstract

Background and Aim: Various scoring systems and markers are used in intensive care practice, and molecules which can predict mortality and change the course of treatment continue to be researched. We aimed to investigate whether uric acid, albumin, uric acid/albumin ratio and uric acid/creatinine ratio were associated with mortality in intensive care cases. Materials and Methods: Our study was designed retrospectively and involved 600 cases. The uric acid and albumin values of the cases were recorded at the time of admission were recorded, and the uric acid/albumin ratio and uric acid/creatine ratio were calculated. APACHE-II scores and SOFA scores of all the patients at the time of admission were recorded. Results: Uric acid, uric/albumin ratio, uric acid/creatinine ratios of Groups AKI and Non-AKI were statistically significant(p<0.001, p<0.001, p<0.001, respectively).When exitus and discharged cases were compared, albumin and uric acid/albumin ratios were statistically significant (p<0.050, p<0.050,in order). The cut-off value for albumin was found as 2.75. Mortality increases at the values below 2.75. A meaningful difference was detected between the distributions of albumin cut-off value according to the last condition of the patients (p=0.038). We discovered a notable correlation between albumin ,uric acid/creatinine ratio , APACHE-II , SOFA scores (p values p=0.045; p=0.012; p=0.018; p=0.020,seriatim). Conclusion: Uric acid/albumin ratio may be a useful biomarker in predicting prognosis in cases of acute kidney injury. We believe that our study will shed light on future studies on the uric acid/albumin ratio in larger populations and different patient groups.

Keywords

Supporting Institution

yok

Ethical Statement

Ordu Üniversitesi Klinik Araştırmalar Etik kurulu ,Karar no: 2019/139, Tarih:10.10.2019

References

  1. Aminiahidashti H, Bozorgi F, Mousavi SJ, Sedighi O, Gorji AM, Rashidian H. Serum Uric Acid Level in Relation to Severity of the Disease and Mortality of Critically Ill Patients. J Lab Physicians. 2017;9(1):42-46.
  2. Lee HW, Choi SM, Lee J, et al. Serum Uric Acid Level as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome. J Intensive Care Med. 2019 ;34(5):404-410.
  3. Akbar SR, Long DM, Hussain K, et al. Hyperuricemia: An Early Marker for Severity of Illness in Sepsis. Int J Nephrol. 2015;2015:301021.
  4. Chen Q, Huang K, Li L, et al. Serum uric acid on admission cannot predict long-term outcome of critically ill patients: a retrospective cohort study. Ther Clin Risk Manag. 2018;14:1347-1359.
  5. Pesquera JIM, Rubio AH, Ruiz IG, et al. La hiperuricemiacomo factor de riesgo cardiovascular y renal. Diálisis y Trasplante. 2011;32(2):57-61.
  6. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008;58(2):623-630.
  7. Dawson J, Jeemon P, Hetherington L, et al. Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension. 2013;62(1):105-111.
  8. Andrassy KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013;84(3):622-623.

Details

Primary Language

English

Subjects

Anaesthesiology

Journal Section

Clinical Research

Early Pub Date

February 29, 2024

Publication Date

January 31, 2024

Submission Date

December 25, 2023

Acceptance Date

January 11, 2024

Published in Issue

Year 2024 Volume: 1 Number: 1

APA
Canakci, E., Alp, M. Ş., Güven, Y. E., & İçöz, Ş. (2024). The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study. Cerasus Journal of Medicine, 1(1), 42-51. https://izlik.org/JA95AB76GS
AMA
1.Canakci E, Alp MŞ, Güven YE, İçöz Ş. The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study. Cerasus J Med. 2024;1(1):42-51. https://izlik.org/JA95AB76GS
Chicago
Canakci, Ebru, Mehmet Şerif Alp, Yunus Emre Güven, and Şükran İçöz. 2024. “The Uric Acid Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study”. Cerasus Journal of Medicine 1 (1): 42-51. https://izlik.org/JA95AB76GS.
EndNote
Canakci E, Alp MŞ, Güven YE, İçöz Ş (January 1, 2024) The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study. Cerasus Journal of Medicine 1 1 42–51.
IEEE
[1]E. Canakci, M. Ş. Alp, Y. E. Güven, and Ş. İçöz, “The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study”, Cerasus J Med, vol. 1, no. 1, pp. 42–51, Jan. 2024, [Online]. Available: https://izlik.org/JA95AB76GS
ISNAD
Canakci, Ebru - Alp, Mehmet Şerif - Güven, Yunus Emre - İçöz, Şükran. “The Uric Acid Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study”. Cerasus Journal of Medicine 1/1 (January 1, 2024): 42-51. https://izlik.org/JA95AB76GS.
JAMA
1.Canakci E, Alp MŞ, Güven YE, İçöz Ş. The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study. Cerasus J Med. 2024;1:42–51.
MLA
Canakci, Ebru, et al. “The Uric Acid Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study”. Cerasus Journal of Medicine, vol. 1, no. 1, Jan. 2024, pp. 42-51, https://izlik.org/JA95AB76GS.
Vancouver
1.Ebru Canakci, Mehmet Şerif Alp, Yunus Emre Güven, Şükran İçöz. The Uric Acid / Albumin Ratio in Acute Kidney Injury Developing in Intensive Care Unit: A Case-Control Study. Cerasus J Med [Internet]. 2024 Jan. 1;1(1):42-51. Available from: https://izlik.org/JA95AB76GS

INDEXING & ABSTRACTING & ARCHIVING



  Cerasus Journal of Medicine, hosted by Dergipark, is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.